×
About 733 results

ALLMedicine™ Urine Sodium Center

Research & Reviews  233 results

Empagliflozin as a Novel Therapy in Refractory Ascites
https://clinicaltrials.gov/ct2/show/NCT05430243

Jun 24th, 2022 - Midodrine will be added if the blood pressure less than 100/70 mmHg during the follow up period (start by dose 5 mg three times daily and up titrate the dose according to the blood pressure monitoring to maximum dose 12.5 mg three times daily. Tre...

Relationship of Sodium Intake With Granulocytes, Renal and Cardiovascular Outcomes in t...
https://doi.org/10.1161/JAHA.121.023727
Journal of the American Heart Association; Wenstedt EFE, Peters Sengers H et. al.

Jun 23rd, 2022 - Background Experimental studies show that high-sodium intake affects the innate immune system, among others with increased circulating granulocytes. Whether this relationship exists on a population level and whether this relates to disease outcome...

Associations of Obesity and Neighborhood Factors With Urinary Stone Parameters.
https://doi.org/10.1016/j.amepre.2022.01.033
American Journal of Preventive Medicine; Crivelli JJ, Redden DT et. al.

Jun 21st, 2022 - Obesity is associated with kidney stone disease, but it is unknown whether this association differs by SES. This study assessed the extent to which obesity and neighborhood characteristics jointly contribute to urinary risk factors for kidney ston...

Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
https://clinicaltrials.gov/ct2/show/NCT05411991

Jun 15th, 2022 - Key interventions are: Assessment of UNa in spot urine samples after every bolus administration of loop diuretics with continuation of intravenous diuretics until resolution of clinical signs of fluid overload AND UNa <80 mmol/L Dosing of loop diu...

Intestinal Gastrin/CCKBR (Cholecystokinin B Receptor) Ameliorates Salt-Sensitive Hypert...
https://doi.org/10.1161/HYPERTENSIONAHA.121.18791
Hypertension (Dallas, Tex. : 1979); Jiang X, Liu Y et. al.

Jun 9th, 2022 - The present study directly tested the crucial role of intestinal gastrin/CCKBR (cholecystokinin B receptor) in the treatment of salt-sensitive hypertension. Adult intestine-specific Cckbr-knockout mice (Cckbrfl/fl villin-Cre) and Dahl salt-sensiti...

see more →

Clinicaltrials.gov  38 results

Empagliflozin as a Novel Therapy in Refractory Ascites
https://clinicaltrials.gov/ct2/show/NCT05430243

Jun 24th, 2022 - Midodrine will be added if the blood pressure less than 100/70 mmHg during the follow up period (start by dose 5 mg three times daily and up titrate the dose according to the blood pressure monitoring to maximum dose 12.5 mg three times daily. Tre...

Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
https://clinicaltrials.gov/ct2/show/NCT05411991

Jun 15th, 2022 - Key interventions are: Assessment of UNa in spot urine samples after every bolus administration of loop diuretics with continuation of intravenous diuretics until resolution of clinical signs of fluid overload AND UNa <80 mmol/L Dosing of loop diu...

Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients With Acute Heart Failure
https://clinicaltrials.gov/ct2/show/NCT04481919

May 25th, 2022 - A standardized protocol driven treatment pathway for hospitalized patients started in the first few hours of ED evaluation and utilizing objective measures of diuretic response is needed. The investigators believe this would maximize diuretic effi...

Estimation Method of 24-hour Urinary Sodium Excretion by Using Spot Urine for Chinese Population
https://clinicaltrials.gov/ct2/show/NCT03204422

Mar 2nd, 2022 - Specific Aims To collect multiple spot urine samples and a 24-h urine sample in a population of Chinese Children and adults. All participants will collect a spot urine in separate jugs during the 24-h period, recording every urination time. Valida...

MANP in African Americans With Hypertension
https://clinicaltrials.gov/ct2/show/NCT04542681

Feb 24th, 2022 - The study is designed in 2 cycles. Cycle 1 will incorporate 20 participants and include a screening / enrollment visit and 1 study visit. The study visit will be 30 hours and involves SQ administration of placebo (n=10) or MANP 2.5 ug/kg (n=10). C...

see more →

News  22 results

Copeptin Rules Out Diabetes Insipidus Post Pituitary Surgery
https://www.medscape.com/viewarticle/970357

Mar 16th, 2022 - The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. Key Takeaways A study of 78 patients who underwent elective transsphenoidal adenomectomy to remove a pituitary tumor or other lesi...

Lower Urinary Sodium, Higher Potassium Tied to Lower CV Risk
https://www.medscape.com/viewarticle/963153

Nov 17th, 2021 - Higher dietary sodium intake, estimated by determining daily excretion from at least two 24-hour urine samples, was associated with an increased risk for a cardiovascular event in a meta-analysis of six cohorts. And higher potassium intake, determ...

High Salt Intake Linked to Increased Heart-Failure Risk
https://www.staging.medscape.com/viewarticle/884824

Aug 28th, 2017 - BARCELONA, SPAIN — High daily salt intake is associated with a substantial increase in an individual's risk of developing heart failure, independent of other risk factors, suggests one of the largest studies to accurately measure salt consumption[...

High Salt Intake Linked to Increased Heart-Failure Risk
https://www.medscape.com/viewarticle/884824

Aug 28th, 2017 - BARCELONA, SPAIN — High daily salt intake is associated with a substantial increase in an individual's risk of developing heart failure, independent of other risk factors, suggests one of the largest studies to accurately measure salt consumption[...

Sunitinib-Induced Acute Intestinal Nephritis
https://www.mdedge.com/fedprac/avaho/article/146368/hematology/sunitinib-induced-acute-intestinal-nephritis
Azar I, Assi H et. al.

Aug 1st, 2017 - Background: A 69-year-old male with history of stage IV left kidney clear cell carcinoma presented with 4-day history of gross hematuria, fever of 101. 4 F and fatigue.

see more →